RECURSION PHARMACEUT

RXRX
Delayed Quote. Delayed  - 05/18 03:55:07 pm
5.615USD -8.10%

Turn to zoom
Prev.6.1100
Open5.8300
High6.0300
Low5.4916
Volume613 245
Latest news
7d ago
7d ago
7d ago
7d ago
Chart RECURSION PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance7,7311,017,1
Spread/Res.-27%-49%-67%
Spread/Supp.12%12%-0,35%
Support5,045,045,64
Financials
Sales 2022 43,7 M - -
Net income 2022 -220 M - -
Net cash 2022 264 M - -
P/E ratio 2022 -3,81x
Yield 2022 -
Capitalization 1 051 M 1 051 M -
EV / Sales 2022 18,0x
EV / Sales 2023 16,3x
Nbr of Employees 450
Free-Float 87,6%
Company
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company decoding biology by integrating technology across biology, chemistry, automation, machine learning, and engineering to industrialize drug discovery. The Company’s platform includes the Recursion Operating System, which...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2022-06-14 Shareholder meeting
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 6,11 $
Average target price 16,00 $
Spread / Average Target 162%